[go: up one dir, main page]

DE60331185D1 - Zusammensetzungen und verfahren zur abgabe von photosensibilisierten arzneimitteln - Google Patents

Zusammensetzungen und verfahren zur abgabe von photosensibilisierten arzneimitteln

Info

Publication number
DE60331185D1
DE60331185D1 DE60331185T DE60331185T DE60331185D1 DE 60331185 D1 DE60331185 D1 DE 60331185D1 DE 60331185 T DE60331185 T DE 60331185T DE 60331185 T DE60331185 T DE 60331185T DE 60331185 D1 DE60331185 D1 DE 60331185D1
Authority
DE
Germany
Prior art keywords
photosensibilized
medicaments
distributing
compositions
nanoparticles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60331185T
Other languages
English (en)
Inventor
Eric Allemann
Yvette Konan
Robert Gurny
Ronald Erwin Boch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novelion Therapeutics Inc
Original Assignee
QLT Inc
Quadra Logic Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QLT Inc, Quadra Logic Technologies Inc filed Critical QLT Inc
Application granted granted Critical
Publication of DE60331185D1 publication Critical patent/DE60331185D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60331185T 2002-05-16 2003-05-16 Zusammensetzungen und verfahren zur abgabe von photosensibilisierten arzneimitteln Expired - Lifetime DE60331185D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38147402P 2002-05-16 2002-05-16
PCT/CA2003/000740 WO2003097096A1 (en) 2002-05-16 2003-05-16 Compositions and methods for delivery of photosensitive drugs

Publications (1)

Publication Number Publication Date
DE60331185D1 true DE60331185D1 (de) 2010-03-25

Family

ID=29550129

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60331185T Expired - Lifetime DE60331185D1 (de) 2002-05-16 2003-05-16 Zusammensetzungen und verfahren zur abgabe von photosensibilisierten arzneimitteln

Country Status (8)

Country Link
US (1) US7455858B2 (de)
EP (1) EP1503796B1 (de)
AT (1) ATE456956T1 (de)
AU (1) AU2003233287A1 (de)
CA (1) CA2484664C (de)
DE (1) DE60331185D1 (de)
ES (1) ES2341646T3 (de)
WO (1) WO2003097096A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03011935A (es) * 2001-06-22 2004-03-26 Pfizer Prod Inc Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco.
US7133547B2 (en) * 2002-01-24 2006-11-07 Tripath Imaging, Inc. Method for quantitative video-microscopy and associated system and computer software program product
US7611630B2 (en) * 2004-03-30 2009-11-03 Bend Research, Inc. Method and device for evaluation of pharmaceutical compositions
US20060222592A1 (en) * 2005-04-05 2006-10-05 Clemens Burda Nanoparticles and methods of manufacturing nanoparticles for electronic and non-electronic applications
WO2006133271A2 (en) * 2005-06-06 2006-12-14 The General Hospital Corporation Compositions and methods relating to target-specific photodynamic therapy
US20100119827A1 (en) * 2006-04-25 2010-05-13 Research Foundation Of The City University Of New York Polymer submicron particle preparation by surfactant-mediated precipitation
WO2008065502A1 (en) * 2006-11-29 2008-06-05 Pfizer Products Inc. Pharmaceutical compositions based on a) nanoparticles comprising enteric polymers and b) casein
WO2008125940A2 (en) * 2007-04-17 2008-10-23 Pfizer Products Inc. Nanoparticles comprising non-crystalline drug
WO2008135828A2 (en) * 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
WO2008135855A2 (en) * 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
US20100080852A1 (en) * 2007-05-03 2010-04-01 Ronald Arthur Beyerinck Phamaceutical composition comprising nanoparticles and casein
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
WO2008149192A2 (en) * 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
US20100215747A1 (en) * 2007-07-13 2010-08-26 Corey Jay Bloom Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
WO2009073216A1 (en) * 2007-12-06 2009-06-11 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an amine-functionalized methacrylate copolymer
WO2009073215A1 (en) * 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
EP2153821A1 (de) * 2008-08-06 2010-02-17 BioAlliance Pharma Orale Formulierungen von Camptothecin-Derivaten
ES2381022T3 (es) 2008-12-19 2012-05-22 Biolitec Ag Nanopartículas de fosfato de calcio como vehículo de colorantes para la terapia fotodinámica
US8815931B2 (en) * 2009-04-28 2014-08-26 Biolitec Pharma Marketing Ltd Oral formulations for tetrapyrrole derivatives
US20110275686A1 (en) * 2009-12-11 2011-11-10 Biolitec, Inc. Nanoparticle carrier systems based on poly(dl-lactic-co-glycolic acid) (plga) for photodynamic therapy (pdt)
US9211283B2 (en) * 2009-12-11 2015-12-15 Biolitec Pharma Marketing Ltd Nanoparticle carrier systems based on human serum albumin for photodynamic therapy
US8916205B2 (en) * 2011-08-11 2014-12-23 Quest Pharmatech Inc. Polymeric nanoparticles for photosensitizers
EP2996677B1 (de) * 2013-05-18 2019-11-20 National Chung-Hsing University Fotosensibilisatorteilchen für die medizinische bildgebung und/oder fotodynamische therapie
US20170119814A1 (en) * 2014-06-17 2017-05-04 Albert Einstein College Of Medicine, Inc. Therapeutic nanoparticles and methods thereof
WO2016054079A1 (en) 2014-09-29 2016-04-07 Zyomed Corp. Systems and methods for blood glucose and other analyte detection and measurement using collision computing
EP3324973B1 (de) 2015-07-21 2020-06-03 Avedro, Inc. Augenbehandlung mit einem photosensibilisator
US9554738B1 (en) 2016-03-30 2017-01-31 Zyomed Corp. Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883790A (en) 1987-01-20 1989-11-28 University Of British Columbia Wavelength-specific cytotoxic agents
JP2564386B2 (ja) 1987-04-16 1996-12-18 クリスチャン ビンチャエドラー 水不溶性ポリマーの粉末の調整方法
US5798349A (en) 1994-03-14 1998-08-25 The General Hospital Corporation Use of green porphyrins to treat neovasculature in the eye
US5707608A (en) * 1995-08-02 1998-01-13 Qlt Phototherapeutics, Inc. Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer
CA2229285A1 (en) 1995-09-21 1997-03-27 Robert Gurny Nanoparticles in photodynamic therapy
US20020127224A1 (en) 2001-03-02 2002-09-12 James Chen Use of photoluminescent nanoparticles for photodynamic therapy

Also Published As

Publication number Publication date
ATE456956T1 (de) 2010-02-15
AU2003233287A1 (en) 2003-12-02
EP1503796B1 (de) 2010-02-03
US20040047913A1 (en) 2004-03-11
ES2341646T3 (es) 2010-06-24
CA2484664A1 (en) 2003-11-27
CA2484664C (en) 2010-07-06
WO2003097096A1 (en) 2003-11-27
EP1503796A1 (de) 2005-02-09
US7455858B2 (en) 2008-11-25

Similar Documents

Publication Publication Date Title
DE60331185D1 (de) Zusammensetzungen und verfahren zur abgabe von photosensibilisierten arzneimitteln
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
CY1111263T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει sns-595 και χρησεις αυτης
ATE450251T1 (de) Liposomale formulierungen mit dihydrosphingomyelin und verfahren zu ihrer verwendung
MXPA05005223A (es) Diaminotriazoles utiles como inhibidores de proteinas cinasas.
PT1730146E (pt) Azaindoles úteis como inibidores de jak e outras proteínas quinases
SG164368A1 (en) Treatment of cancer
DE602004031462D1 (de) Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung
CY1106601T1 (el) Χρηση του παραγωγου κουιναζολινης zd6474 συνδυασμενου με γκεμσιταμπινη και προαιρετικα με ιοντιζουσα ακτινοβολια στη θεραπεια του καρκινου
IL173348A (en) Thienopyridine compounds, pharmaceuticals containing them and their use in the preparation of drugs
ATE350377T1 (de) Substituierte 3-pyrrolidin-indol-derivate
ATE355288T1 (de) Verbindungen und therapeutische methoden
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
GB0802753D0 (en) Perylenequinone derivatives and uses thereof
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
TW200630090A (en) Triazoles useful as inhibitors of protein kinases
BRPI0418157A (pt) terapêutica de tumores alogênicos
EA200501166A1 (ru) Составы и способы лечения тромбоцитемии
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
PL1606233T3 (pl) Estry fosfolipidowe klofarabiny
DE60334289D1 (de) Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen
ATE460168T1 (de) Nicht-radioaktives strontiummittel zur behandlung von krebs
TW200501958A (en) A therapeutic agent for treating a behavioral disorder
ATE412411T1 (de) Pmcol zur behandlung von prostatakrebs
DE602004016547D1 (de) 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition